Literature DB >> 20005982

Adalimumab level in breast milk of a nursing mother.

Shomron Ben-Horin, Miri Yavzori, Lior Katz, Orit Picard, Ella Fudim, Yehuda Chowers, Alon Lang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20005982     DOI： 10.1016/j.cgh.2009.11.023

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  25 in total

Review 1.  Managing IBD Therapies in Pregnancy.

Authors:  Jill K J Gaidos; Sunanda V Kane
Journal:  Curr Treat Options Gastroenterol       Date:  2017-03

2.  IBD: Exposure to anti-TNF agents in utero: controlling health risks.

Authors:  C Janneke van der Woude; Shannon L Kanis
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-06-02       Impact factor: 46.802

Review 3.  Use of DMARDs and biologics during pregnancy and lactation in rheumatoid arthritis: what the rheumatologist needs to know.

Authors:  Megan L Krause; Shreyasee Amin; Ashima Makol
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-10       Impact factor: 5.346

Review 4.  A Pharmacological Approach to Managing Inflammatory Bowel Disease During Conception, Pregnancy and Breastfeeding: Biologic and Oral Small Molecule Therapy.

Authors:  Sherman Picardo; Cynthia H Seow
Journal:  Drugs       Date:  2019-07       Impact factor: 9.546

Review 5.  IBD in pregnancy: recent advances, practical management.

Authors:  Christian P Selinger; Catherine Nelson-Piercy; Aileen Fraser; Veronica Hall; Jimmy Limdi; Lyn Smith; Marie Smith; Reem Nasur; Melanie Gunn; Andrew King; Aarthi Mohan; Khasia Mulgabal; Alexandra Kent; Klaartje Bel Kok; Tracey Glanville
Journal:  Frontline Gastroenterol       Date:  2020-05-19

Review 6.  Tumor Necrosis Factor-Alpha and Pregnancy: Focus on Biologics. An Updated and Comprehensive Review.

Authors:  Jaume Alijotas-Reig; Enrique Esteve-Valverde; Raquel Ferrer-Oliveras; Elisa Llurba; Josep Maria Gris
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

Review 7.  Tumor necrosis factor-α inhibitor therapy and fetal risk: a systematic literature review.

Authors:  Renée M Marchioni; Gary R Lichtenstein
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

8.  Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease.

Authors:  Uma Mahadevan; Douglas C Wolf; Marla Dubinsky; Antoine Cortot; Scott D Lee; Corey A Siegel; Thomas Ullman; Sarah Glover; John F Valentine; David T Rubin; Jocelyn Miller; Maria T Abreu
Journal:  Clin Gastroenterol Hepatol       Date:  2012-11-28       Impact factor: 11.382

Review 9.  Management of Inflammatory Bowel Disease During Pregnancy.

Authors:  Ariella Bar-Gil Shitrit; Sorina Grisaru-Granovsky; Ami Ben Ya'acov; Eran Goldin
Journal:  Dig Dis Sci       Date:  2016-04-11       Impact factor: 3.199

Review 10.  From conception to delivery: managing the pregnant inflammatory bowel disease patient.

Authors:  Vivian W Huang; Flavio M Habal
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.